Submission of outcome of the Board meeting held on 11th December, 2025.

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹61.23

prior close

₹64.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-1.2% vs market

Healthcare Services peers, median of 51sector · industry level+0.3%-1.2% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.2 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.5

10m

-3.5

15m

-0.2

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+0.3-1.2+0.3-1.2

Next day

-0.2+0.8-1.0+0.6-0.9

+1.3+0.1+1.1+0.7+0.6

-2.0-0.8-1.3-0.1-1.9

-0.4-1.1+0.7-0.8+0.4

+3.0+0.2+2.8-0.3+3.3

-4.6+1.6-6.2-0.3-4.3

15d

-3.9+2.5-6.4+0.4-4.3

-8.5-2.7-5.9-2.4-6.2

+0.1-0.3+0.4-5.7+5.8

-7.5-8.9+1.5-12.7+5.2

UpDownMarket · Nifty Microcap 250Sector · Healthcare Services peers, median of 51Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board of Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) on 11th December 2025 approved a preferential issue of 25,00,000 (25 lakh) equity shares at Rs. 60 per share, with a face value of Rs. 10 and a premium of Rs. 50 per share, totaling Rs. 15 crore. The shares will be allotted to 40 allottees, including promoters, promoter group members, and non-promoters, subject to shareholder approval at an Extra Ordinary General Meeting (EGM) scheduled for 9th January 2026. This capital raise is being done under Sections 42 and 62 of the Companies Act and SEBI's ICDR Regulations to raise additional capital. An EGM notice has been approved, and a scrutinizer has been appointed for the e-voting process, with the cut-off date set as 2nd January 2026.

Likely market impact

This preferential allotment will dilute existing shareholders by issuing new equity at a significant premium, bringing in Rs. 15 crore of fresh capital. Existing public shareholders should monitor the EGM on 9th January 2026, as their approval is required for the issue to proceed.